Enzyme replacement therapy in Fabry disease: Comparison of agalsidase alfa and agalsidase beta

被引：20
作者：
Mehta, Atul [1 ]
Beck, Michael [2 ]
Kampmann, Christoph [2 ]
Frustaci, Andrea [3 ]
Germain, Dominique P. [4 ]
Pastores, Gregory M. [5 ]
Sunder-Plassmann, Gere [6 ]
机构：
[1] UCL Royal Free & Univ Coll Med Sch, Dept Acad Haematol, London NW3 2QG, England
[2] Univ Childrens Hosp, Mainz, Germany
[3] Univ Roma La Sapienza, Heart & Great Vessels Attilio Reale Dept, Rome, Italy
[4] Univ Versailles St Quentin Yvelines, Hop Raymond Poincare, AP HP, UF Genet Med, Garches, France
[5] NYU, Sch Med, Dept Neurol & Pediat, New York, NY USA
[6] Dept Internal Med 3, Div Nephrol & Dialysis, Vienna, Austria
来源：
MOLECULAR GENETICS AND METABOLISM | 2008年 / 95卷 / 1-2期
关键词：
D O I：
10.1016/j.ymgme.2008.07.002
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：114 / 115
页数：2
相关论文
共 15 条
  • [1] Enzyme replacement therapy in heterozygous females with Fabry disease: Results of a phase IIIB study
    Baehner, F
    Kampmann, C
    Whybra, C
    Miebach, E
    Wiethoff, CM
    Beck, M
    [J]. JOURNAL OF INHERITED METABOLIC DISEASE, 2003, 26 (07) : 617 - 627
  • [2] Agalsidase-beta therapy for advanced Fabry disease - A randomized trial
    Banikazemi, Maryam
    Bultas, Jan
    Waldek, Stephen
    Wilcox, William R.
    Whitley, Chester B.
    McDonald, Marie
    Finkel, Richard
    Packman, Seymour
    Bichet, Daniel G.
    Warnock, David G.
    Desnick, Robert J.
    [J]. ANNALS OF INTERNAL MEDICINE, 2007, 146 (02) : 77 - 86
  • [3] Fabry disease: overall effects of agalsidase alfa treatment
    Beck, M
    Ricci, R
    Widmer, U
    Dehout, F
    de Lorenzo, AG
    Kampmann, C
    Linhart, A
    Sunder-Plassmann, G
    Houge, G
    Ramaswami, U
    Gal, A
    Mehta, A
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2004, 34 (12) : 838 - 844
  • [4] Successful reinstitution of agalsidase beta therapy in Fabry disease patients with previous IgE-antibody or skin-test reactivity to the recombinant enzyme
    Bodensteiner, David
    Scott, C. Ronald
    Sims, Katherine B.
    Shepherd, Gillian M.
    Cintron, Rebecca D.
    Germain, Dominique P.
    [J]. GENETICS IN MEDICINE, 2008, 10 (05) : 353 - 358
  • [5] The pharmacology of multiple regimens of agalsidase alfa enzyme replacement therapy for Fabry disease
    Clarke, Joe T. R.
    West, Michael L.
    Bultas, Jan
    Schiffmann, Raphael
    [J]. GENETICS IN MEDICINE, 2007, 9 (08) : 504 - 509
  • [6] Safety and efficacy of recombinant human α-galactosidase a replacement therapy in Fabry's disease.
    Eng, CM
    Guffon, N
    Wilcox, WR
    Germain, DP
    Lee, P
    Waldek, S
    Caplan, L
    Linthorst, GE
    Desnick, RJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (01) : 9 - 16
  • [7] Effects of enzyme replacement therapy on the cardiomyopathy of Anderson-Fabry disease: a randomised, double-blind, placebo-controlled clinical trial of agalsidase alfa
    Hughes, D. A.
    Elliott, P. M.
    Shah, J.
    Zuckerman, J.
    Coghlan, G.
    Brookes, J.
    Mehta, A. B.
    [J]. HEART, 2008, 94 (02) : 153 - 158
  • [8] Kampmann C., 2006, FABRY DIS PERSPECTIV
  • [9] Lee SY, 2003, J MICROBIOL BIOTECHN, V13, P313
  • [10] Enzyme-replacement therapy with agalsidase alfa in children with Fabry disease
    Ries, Markus
    Clarke, Joe T. R.
    Whybra, Catharina
    Timmons, Margaret
    Robinson, Chevalia
    Schlaggar, Bradley L.
    Pastores, Gregory
    Lien, Y. Howard
    Kampmann, Christoph
    Brady, Roscoe O.
    Beck, Michael
    Schiffmann, Raphael
    [J]. PEDIATRICS, 2006, 118 (03) : 924 - 932
12